In summary, the current investigation indicates that combined detection of the expression of CEA, p53, Ki-67 and GST-π in colorectal cancer may be of value in understanding the aggressive behavior of colorectal cancer such as the growth, recurrence, and metastasis of the tumor, and may provide useful information on the prognosis of patients with this type of cancer. Here, TP53 is linked to colorectal cancer.